Zeng B. Zhu

Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma

Mariam A. Stoff‐Khalili, Ángel A. Rivera, J. Michael Mathis et al. · Breast Cancer Research and Treatment · 2007 · 206 citations

Medicine, Cancer Biology, Oncology +12

Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes.

Frederick M. Schaffer, John Palermos, Zeng B. Zhu et al. · Proceedings of the National Academy of Sciences · 1989 · 161 citations · Full text

Life Sciences, Genetics, Immunology +17

Survivin-Driven and Fiber-Modified Oncolytic Adenovirus Exhibits Potent Antitumor Activity in Established Intracranial Glioma

Ilya V. Ulasov, Zeng B. Zhu, Matthew A. Tyler et al. · Human Gene Therapy · 2007 · 127 citations

Life Sciences, Molecular Biology, Oncology +15

Transcriptional targeting of tumors with a novel tumor-specific survivin promoter

Zeng B. Zhu, Sharmila Makhija, Baogen Lu et al. · Cancer Gene Therapy · 2004 · 104 citations

Medicine, Cancer Biology, Oncology +14

The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma

Winan J. van Houdt, Yosef S. Haviv, Baogen Lu et al. · Journal of neurosurgery · 2006 · 89 citations

Medicine, Biotechnology, Oncology +17